Delivery Order SPE2DB20D2014-SPE2DB24FC51S

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,963.85 firm fixed-price delivery order is for the supply of 56 tablets of the drug Varenicline 1 mg. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,025.61, is for the delivery of Varenicline 1 mg tablets. It is a firm fixed price contract with a completion date of September 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.14 firm fixed-price delivery order is for the supply of 4,566,615,835 units of the medication Varenicline 0.5 mg tablet. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract has a ceiling value of $1,242.50 and a period of performance through January 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 56 tablets of Varenicline 1 mg, a prescription medication. The contract has a firm fixed price of $2,809.24 and a completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its broader federal contracting activities with the DLA and other agencies. The company holds significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 56 tablets of the drug varenicline (0.5 mg). The contract has a firm fixed price of $5,068.69 and a completion date of November 15, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract has a firm fixed price of $1,674.34 and a period of performance through January 30, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $2,971.48, is for the delivery of 56 tablets of the medication varenicline 1 mg. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of 56 tablets of the medication varenicline 0.5 mg, with a potential value of $1,137.16 and a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 56 tablets of the medication Varenicline 1 mg. The firm-fixed-price delivery order has a ceiling value of $2,512.45 and an ultimate completion date of May 5, 2023. The contract is not designated as a set-aside. AmerisourceBergen is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) worth $999,999,999 with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC51S
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of varenicline 0.5 mg tablets. The contract has a firm fixed price of $8,407.26 and an ultimate completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC allows the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, from AmerisourceBergen to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside designation.

Generated 10/17/24, 9:25 AM